Sabra Healthcare REIT, Inc. (SBRA) is a publicly traded Real Estate sector company. As of July 13, 2026, SBRA trades at $19.87 with a market cap of $4.95B and a P/E ratio of 31.13. SBRA moved +1.12% today. Year to date, SBRA is +3.32%; over the trailing twelve months it is +6.80%. Its 52-week range spans $15.60 to $21.28. Analyst consensus is neutral with an average price target of $21.19. Rallies surfaces SBRA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks SBRA insider trades, Form 4 activity, executive purchases, executive sales, shares, prices, and transaction dates when available.
| Metric | Value |
|---|---|
| Price | $19.87 |
| Market Cap | $4.95B |
| P/E Ratio | 31.13 |
| EPS | $0.63 |
| Dividend Yield | 0.30% |
| 52-Week High | $21.28 |
| 52-Week Low | $15.60 |
| Volume | 120.26K |
| Avg Volume | 0 |
| Revenue (TTM) | $812.84M |
| Net Income | $156.02M |
| Gross Margin | 0.00% |
9 analysts cover SBRA: 0 strong buy, 2 buy, 6 hold, 1 sell, 0 strong sell. Consensus rating is neutral. Average price target: $21.19.